Current Cardiovascular Drugs /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Frishman, William H. (Editor ), Cheng-Lai, Angela. (Editor ), Chen, Julie. (Editor )
Formato: eBook
Lenguaje:English
Publicado: London : Current Medicine Group : Imprint: Current Medicine Group, 2000.
Edición:3rd ed. 2000.
Materias:
LEADER 01710nam a22003255i 4500
001 000282466
005 20211102133832.0
007 cr nn 008mamaa
008 130622s2000 xxk| s |||| 0|eng d
020 |a 9781461567677 
024 7 |a 10.1007/978-1-4615-6767-7  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Current Cardiovascular Drugs /  |c edited by William H. Frishman, Angela Cheng-Lai, Julie Chen. 
250 |a 3rd ed. 2000. 
260 # # |a London :  |b Current Medicine Group :  |b Imprint: Current Medicine Group,  |c 2000. 
300 |a VIII, 342 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a How to Use This Book -- Alpha-Adrenergic Blockers (Peripherally Acting Antihypertensive Agents) -- Alpha2-Adrenergic Agonists (Centrally Acting Antihypertensive Agents) -- Angiotensin-Converting Enzyme Inhibitors -- Angiotensin-II Receptor Blockers -- Antiarrhythmic Agents -- Antithrombotic Therapy -- Beta-Adrenergic Blockers -- Calcium Antagonists -- Diuretics -- Inotropic and Vasopressor Agents -- Lipid-Lowering Drugs -- Neuronal and Ganglionic Blockers -- Vasodilators (Other Agents and Drug Classes) -- Drugs in Development: New Agents, New Classes, New Indications. 
650 0 |a Pharmacology. 
650 0 |a Cardiology. 
650 1 4 |a Pharmacology/Toxicology. 
650 2 4 |a Cardiology. 
700 1 |a Frishman, William H.  |e editor. 
700 1 |a Cheng-Lai, Angela.  |e editor. 
700 1 |a Chen, Julie.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
900 |a Libro descargado a ALEPH en bloque (proveniente de proveedor)